Humana (NYSE:HUM) Shares Bought Rep. Lisa C. McClain

Representative Lisa C. McClain (R-Michigan) recently bought shares of Humana Inc. (NYSE:HUM). In a filing disclosed on November 21st, the Representative disclosed that they had bought between $1,001 and $15,000 in Humana stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB 401K > SCHWAB 893” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Humana Stock Up 3.3%

Shares of HUM opened at $245.73 on Thursday. The company’s 50-day moving average price is $263.71 and its 200 day moving average price is $256.78. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a market cap of $29.55 billion, a P/E ratio of 18.86, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana’s revenue was up 11.1% compared to the same quarter last year. During the same quarter last year, the firm posted $4.16 earnings per share. On average, sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s payout ratio is 33.18%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several research reports. Morgan Stanley dropped their target price on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a report on Thursday, July 31st. Sanford C. Bernstein raised their price target on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. The Goldman Sachs Group cut their price objective on Humana from $235.00 to $215.00 and set a “sell” rating on the stock in a report on Monday. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a report on Wednesday, October 8th. Finally, Wolfe Research cut their price target on shares of Humana from $313.00 to $300.00 and set an “outperform” rating on the stock in a research note on Thursday, November 20th. Eight equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Humana presently has an average rating of “Hold” and an average price target of $295.94.

Hedge Funds Weigh In On Humana

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Cary Street Partners Investment Advisory LLC raised its holdings in Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after acquiring an additional 46 shares in the last quarter. Elevation Point Wealth Partners LLC acquired a new stake in shares of Humana in the 2nd quarter valued at $32,000. Mather Group LLC. purchased a new stake in shares of Humana during the 3rd quarter worth $34,000. Zions Bancorporation National Association UT acquired a new position in shares of Humana during the first quarter worth $37,000. Finally, AlphaCore Capital LLC purchased a new position in Humana in the second quarter valued at $39,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.